3 (rs11568821) and CTLA-4 49A/G (rs231775) SNPs, pretreatment clinical factors as age, gender, insulin resistance, AFP, liver function tests and viral load, with the efficacy of PegIFNα+RBV treatment in Egyptian patients with chronic HCV genotype 4 infection. Here, AFP is linked to Insulin resistance.